Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease
Savelkoul, E H J, Maas, M H J, Bourgonje, A R, Crouwel, F, Biemans, V B C, den Broeder, N, Russel, M G V M, Römkens, T E H, de Boer, N K, Dijkstra, G, Hoentjen, F
Published in Journal of Crohn's and colitis (08.09.2022)
Published in Journal of Crohn's and colitis (08.09.2022)
Get full text
Journal Article
P317 Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn’s Disease
Straatmijer, T, Biemans, V B C, Moes, D J A R, Hoentjen, F, ter Heine, R, Maljaars, P W J, Theeuwen, R, Pierik, M, Duijvestein, M, van der Meulen, A E
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
P286 Ustekinumab for Crohn’s Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
Straatmijer, T, Biemans, V B C, Hoentjen, F, de Boer, N K H, Bodelier, A G, Dijkstra, G, van Dop, W, Haans, J J L, Jansen, J M, Maljaars, P W J, van der Marel, S, Oldenburg, B, Ponsioen, C Y, Visschedijk, M C, de Vries, A C, West, R, van der Woude, C J, Pierik, M, Duijvestein, M, van der Meulen- de Jong, A E
Published in Journal of Crohn's and colitis (27.05.2021)
Published in Journal of Crohn's and colitis (27.05.2021)
Get full text
Journal Article
P340 Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patients
Asscher, V, Biemans, V, Pierik, M, Dijkstra, G, Van der Meulen-de Jong, A, Löwenberg, M, van der Marel, S, de Boer, N, Bodelier, A, Jansen, J, West, R, Haans, J, van Dop, W, Weersma, R, Hoentjen, F, Maljaars, J
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
P503 Two year experience with vedolizumab in inflammatory bowel disease patients: results of the ICC case series, a nationwide prospective observational cohort study
Biemans, V, van der Woude, J, Dijkstra, G, van der Meulen-de Jong, A, Oldenburg, B, de Boer, N, Löwenberg, M, Srivastava, N, Jansen, J, West, R, de Vries, A, Haans, J, Pierik, M, Hoentjen, F
Published in Journal of Crohn's and colitis (25.01.2019)
Published in Journal of Crohn's and colitis (25.01.2019)
Get full text
Journal Article
DOP58 Tofacitinib for ulcerative colitis: Results of the ICC Registry, a nationwide prospective observational cohort study
Biemans, V B, Sleutjes, J A M, de Vries, A C, Bodelier, A G, Dijkstra, G, Oldenburg, B, Löwenberg, M, van Bodegraven, A A, van der Meulen-de Jong, A E, de Boer, N K, Srivastava, N, West, R L, Römkens, T, Horjus Talabur Horje, C S, Jansen, J M, Hoekstra, J, Weersma, R K, van Schaik, F D, Hoentjen, F, Pierik, M J
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
DOP74 Effectiveness of dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy: A multicentre international cohort study
Kopylov, U, Hanzel, J, Liefferinckx, C, De Marco, D, Imperatore, N, Plevris, N, Baston-Rey, I, Harris, R, Truyens, M, Domislovic, V, Vavricka, S, Biemans, V, Myers, S, Shaji, S, Ben-Horin, S, González Lama, Y, Gilletta, C, Bar-Gil Shitrit, A, Zelinkova, Z, Weishof, R, Storan, D, Zittan, E, Franchimont, D, Cremer, A, Afif, W, Castiglione, F, Lees, C, Barrero de Acosta, M, Lobaton, T, Doherty, G, Krznaric, Z, Pierik, M, Hoentjen, F, Drobne, D
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
DOP036 Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study (ICC case series)
Biemans, V, van der Meulen - de Jong, A, van der Woude, C, de Boer, N, Dijkstra, G, Oldenburg, B, Ponsioen, C, Maljaars, P, Haans, J, Pierik, M, Hoentjen, F
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
DOP052 Vedolizumab vs. ustekinumab for Crohn’s disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
Biemans, V, van der Woude, C, van der Meulen - de Jong, A, Dijkstra, G, de Boer, N, Oldenburg, B, Ponsioen, C, de Vries, A, Wintjens, D, Hoentjen, F, Pierik, M
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
P587 Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series
Biemans, V, van der Woude, C, Dijkstra, G, van der Meulen - de Jong, A, Oldenburg, B, de Boer, N, Ponsioen, C, de Vries, A, Haans, J, Pierik, M, Hoentjen, F
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article
P450 Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts
Biemans Drs, V, Savelkoul, E, Dijkstra, G, Simsek, M, Gabriels, R, Pierik, M, West, R, de Boer, N, Hoentjen, F
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
DOP77 Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn’s disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry
Biemans drs, V, van der Woude, J, Dijkstra, G, van der Meulen- de Jong, A, Löwenberg, M, de Boer, N, Oldenburg, B, Srivastava, N, Jansen, J, Bodelier, A, West, R, de Vries, A, Haans, J, de Jong, D, Hoentjen, F, Pierik, M
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article